Psoriatic Arthritis is a chronic inflammatory musculoskeletal disease associated with psoriasis and belonging to the broader family of spondyloarthritis. It can cause joint pain, swelling and stiffness and may involve peripheral joints, the spine, entheses where tendons or ligaments attach to bone, fingers and toes, and other tissues. The relationship with psoriasis is important but not absolute: some people develop joint symptoms before obvious skin psoriasis, so absence of a known skin diagnosis does not exclude Psoriatic Arthritis. NHS guidance identifies joint pain, swelling and stiffness, swollen fingers or toes and nail changes among characteristic features. The condition can cause progressive structural damage if inflammation is not adequately controlled.
The biological basis of Psoriatic Arthritis involves dysregulation of the immune system with important roles for inflammatory pathways involving tumour necrosis factor, interleukin-17, interleukin-23 and related signalling networks. Genetic susceptibility is substantial, and environmental factors can influence disease expression. The disease is heterogeneous, meaning one person may have predominantly peripheral arthritis while another has axial inflammation, enthesitis or dactylitis. Skin and joint disease do not always track together in severity. This heterogeneity is one reason treatment selection increasingly considers the specific domains of disease present rather than assuming that one standard clinical pattern applies to everyone.
The joints affected by Psoriatic Arthritis can include the fingers, toes, knees, ankles and other peripheral joints, while axial disease can affect the sacroiliac joints and spine. Dactylitis produces diffuse swelling of an entire finger or toe rather than isolated swelling at a single joint. Enthesitis causes pain and inflammation at tendon or ligament attachment sites and can occur around the heel or other areas. Nail disease can include pitting, discolouration or separation of the nail from its bed. These manifestations provide useful clinical clues and help distinguish Psoriatic Arthritis from conditions such as Rheumatoid Arthritis and Osteoarthritis. The pattern can also change over time, making longitudinal assessment important.
Diagnosis of Psoriatic Arthritis is based on clinical history, examination, psoriasis or family history, musculoskeletal pattern and investigations used to exclude competing diagnoses. There is no single blood test that definitively proves the condition. Blood tests may assess inflammatory markers and help exclude other inflammatory arthritides, while X-rays can show characteristic structural changes in established disease. Ultrasound and MRI can detect synovitis, enthesitis or inflammatory changes that are not visible on conventional radiographs. Joint-fluid analysis may be necessary when crystal arthritis or infection is a possibility. The presence of psoriasis increases diagnostic suspicion, but joint inflammation should still be evaluated on its own clinical merits.
Treatment aims to control inflammation, prevent structural damage, preserve physical function and manage associated skin disease. NSAIDs may relieve pain and stiffness in milder disease, while conventional DMARDs can be used particularly for peripheral arthritis. Biologic and targeted therapies can inhibit specific inflammatory pathways and are selected according to the dominant disease manifestations, previous treatments and individual factors. Physiotherapy and exercise can maintain mobility and strength, while occupational therapy can help with hand function and adaptation of daily activities. Treatment is generally long-term and may require adjustment because Psoriatic Arthritis can fluctuate and because different manifestations may respond differently to the same medicine.
Psoriatic Arthritis differs from Rheumatoid Arthritis in its association with psoriasis, nail disease, dactylitis, enthesitis and particular patterns of spinal involvement. Unlike Osteoarthritis, it is an inflammatory immune-mediated disease and can cause prolonged stiffness and swollen joints. Unlike Gout, its inflammation is not caused by urate crystals. Unlike Ankylosing Spondylitis, which is a specific form of axial spondyloarthritis, Psoriatic Arthritis can involve both peripheral and axial disease and has the defining association with psoriasis. Nevertheless, considerable overlap exists among inflammatory arthritides, and specialist assessment may be required when the clinical pattern is atypical.
Psoriatic Arthritis has important extra-articular relationships. People with psoriasis and Psoriatic Arthritis may have increased risks of cardiometabolic conditions, and systemic inflammation can contribute to broader health burden. Fatigue can be substantial even when visible joint swelling is limited. Skin disease can affect body image and quality of life, while hand and foot involvement can interfere with work and daily activities. Because psoriasis and arthritis can affect different domains independently, effective management often requires coordination between rheumatology, dermatology, primary care and rehabilitation services. The severity of skin psoriasis does not reliably predict the severity of joint disease, so both must be assessed separately.
The historical understanding of Psoriatic Arthritis evolved from treating joint disease as a complication of psoriasis to recognising it as a distinct inflammatory arthritis with heterogeneous clinical forms. Modern classification and imaging have improved recognition of axial disease, enthesitis and dactylitis, while targeted biologic therapies have expanded treatment options. A common misconception is that someone without extensive psoriasis cannot have Psoriatic Arthritis; skin disease can be subtle or may appear later. Another misconception is that joint pain is simply part of ageing. Persistent swelling, prolonged stiffness, nail changes, dactylitis or inflammatory back pain warrant appropriate medical assessment because early disease control can reduce the risk of irreversible structural damage.
